Patents by Inventor Xiaohong Chang

Xiaohong Chang has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • T cell epitope peptides of ovarian cancer anti-idiotypic antibody 6B11 and use thereof
    Patent number: 8110654
    Abstract: The present invention provides two T-cell epitode peptides of anti-idiotype antibody 6B11 of ovarian cancer, the sequences of which are shown in SEQ ID NO:3 or 6. The present invention also provides the use of such T-cell epitope peptides in the manufacture of vaccines against ovarian cancer and in the treatment and prevention of ovarian cancer. The T-cell epitope peptides of the present invention could specifically kill ovarian cancer cells which are OC166-9 positive, and could find a wide use in the treatment and prevention of ovarian cancer.
    Type: Grant
    Filed: June 4, 2007
    Date of Patent: February 7, 2012
    Assignee: Peking University People;s Hospital
    Inventors: Heng Cui, Wei Li, Xiaohong Chang, Jie Feng, Hongyan Cheng, Huifang Guo, Yexia Cheng
  • T CELL EPITOPE PEPTIDES OF 6B11 OVARIAN CANCER ANTI-IDIOTYPIC ANTIBODY
    Publication number: 20090269366
    Abstract: The present invention provides two T-cell epitode peptides of anti-idiotype antibody 6B11 of ovarian cancer, the sequences of which are shown in SEQ ID NO:3 or 6. The present invention also provides the use of such T-cell epitope peptides in the manufacture of vaccines against ovarian cancer and in the treatment and prevention of ovarian cancer. The T-cell epitope peptides of the present invention could specifically kill ovarian cancer cells which are OC166-9 positive, and could find a wide use in the treatment and prevention of ovarian cancer.
    Type: Application
    Filed: June 4, 2007
    Publication date: October 29, 2009
    Inventors: Heng Cui, Wei Li, Xiaohong Chang, Jie Feng, Hongyan Cheng, Huifang Guo, Yexia Cheng